A win turned to a No Decision from a women’s bantamweight bout at UFC 166 as The Texas Department of Licensing and Regulation overturned the fight after what was initially reported as a failed drug test. The fight was originally a win for Eye (10-1, 1 ND) via unanimous decision.
With a failed drug test, reportedly due a blood thinner from Bleacher Report, the one who failed is often suspended from action for some time. In Eye’s case, she was on a probation instead which likely bars her from competition in Texas, but doesn’t do so when she fights in other states either way.
This means that the scheduled UFC 170 bout between Eye and Alexis Davis (15-5) in a bout that was just recently promoted to the main card with an injury to Rustam Khabilov who was set to face Rafael dos Anjos.
Here is what the UFC had to say about the situation:
“The UFC received word of the fully probated suspension and fine issued to Jessica Eye by the Texas Department of Licensing and Regulation. The UFC intends to honor the probation, which will not force Eye to miss her scheduled bout at UFC 170.”
Jessica Eye also released a statement through the UFC as well:
“I was recently alerted to the fact that I was issued a fully probated suspension and fine by the Texas Department of Licensing and Regulation. While I intend to discuss with the Texas Department of Licensing and Regulation the overturning of my victory at UFC 166, I have accepted the terms of the probation and intend to compete at UFC 170 on Feb. 22. I pride myself on following the rules and representing my family, teammates, sponsors, and fans in the best light possible. I apologize for any distractions this has caused.”
For updates on this situation visit SciFighting.com